Stephen Baxter
Stock Analyst at Wells Fargo
(3.40)
# 993
Out of 5,130 analysts
241
Total ratings
52.87%
Success rate
2.26%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Overweight | $165 → $208 | $181.50 | +14.60% | 22 | Jan 7, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $403 → $424 | $372.83 | +13.72% | 15 | Jan 7, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $35 → $43 | $46.61 | -7.75% | 25 | Jan 7, 2026 | |
| PNTG The Pennant Group | Maintains: Overweight | $31 → $38 | $28.13 | +35.09% | 4 | Jan 7, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $252 → $229 | $201.20 | +13.82% | 17 | Jan 7, 2026 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $431 → $452 | $472.07 | -4.25% | 18 | Jan 7, 2026 | |
| CYH Community Health Systems | Maintains: Underweight | $3 → $2 | $3.32 | -39.76% | 12 | Jan 7, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $39 → $43 | $37.53 | +14.58% | 8 | Jan 7, 2026 | |
| HUM Humana | Downgrades: Equal-Weight | $290 | $276.85 | +4.75% | 13 | Jan 7, 2026 | |
| UHS Universal Health Services | Downgrades: Equal-Weight | $259 → $235 | $207.03 | +13.51% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $17.73 | -37.96% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $80.30 | +27.02% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $354 → $405 | $335.69 | +20.65% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $816.06 | +12.00% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.99 | +0.80% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $278.95 | +7.55% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $185 → $221 | $201.11 | +9.89% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $343.98 | +16.29% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.46 | +101.07% | 3 | Apr 29, 2024 |
Molina Healthcare
Jan 7, 2026
Maintains: Overweight
Price Target: $165 → $208
Current: $181.50
Upside: +14.60%
Elevance Health
Jan 7, 2026
Maintains: Overweight
Price Target: $403 → $424
Current: $372.83
Upside: +13.72%
Centene
Jan 7, 2026
Maintains: Equal-Weight
Price Target: $35 → $43
Current: $46.61
Upside: -7.75%
The Pennant Group
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $28.13
Upside: +35.09%
Tenet Healthcare
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $201.20
Upside: +13.82%
HCA Healthcare
Jan 7, 2026
Maintains: Equal-Weight
Price Target: $431 → $452
Current: $472.07
Upside: -4.25%
Community Health Systems
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $3.32
Upside: -39.76%
BrightSpring Health Services
Jan 7, 2026
Maintains: Overweight
Price Target: $39 → $43
Current: $37.53
Upside: +14.58%
Humana
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $290
Current: $276.85
Upside: +4.75%
Universal Health Services
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $259 → $235
Current: $207.03
Upside: +13.51%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $17.73
Upside: -37.96%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $80.30
Upside: +27.02%
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $335.69
Upside: +20.65%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $816.06
Upside: +12.00%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.99
Upside: +0.80%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $278.95
Upside: +7.55%
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $201.11
Upside: +9.89%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $343.98
Upside: +16.29%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.46
Upside: +101.07%